遗传性血管神经性喉水肿1例
作者:

Hereditary angioneurotic laryngeal edema: a case report
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • | |
    摘要:

    目的 通过报道1例遗传性血管神经性喉水肿(HALE)患者的发病和诊治经过,以提高临床医师对HALE这一罕见病的认识。方法 患者,女,71岁,因"咽痛、呼吸困难伴颈部肿胀半天"、以"喉水肿"收住院。患者反复发作喉水肿、颜面水肿、四肢水肿50余年,外院一直不能明确诊断。结果 入院后积极给予对症应急处理,患者口唇颜面及颈部肿胀较前明显减轻,完善补体C4和补体C1酯酶抑制剂检查考虑为HALE,患者后赴北京查补体C1抑制物0.05 g/L,确诊为HALE,现采用达那唑治疗中,发作频率明显减少。结论 HALE是一种罕见且有致命威胁的疾病,有家族遗传倾向,易误诊,临床医生应提高认知度,避免严重并发症的发生。

    Abstract:

    Objective This paper reports the pathogenesis, diagnosis and treatment of a case of HALE (hereditary angioneurotic laryngeal edema, HALE) in order to improve clinicians' awareness of HALE as a rare disease. Methods It was reported for a case of a 71-year-old female admitted with "sore throat, dyspnea and neck swelling for a long time" and "laryngeal edema". The patient suffered from recurrent laryngeal edema, facial edema and limb edema for more than 50 years, which could not be clearly diagnosed. Results After admission, the patient was given symptomatic emergency treatment, and the swelling of the mouth, face and neck of the patient was significantly reduced. The complement C4 and complement C1 esterase inhibitor tests confirmed that the patient was diagnosed as HALE. The patient went to Beijing for examination of complement C1 esterase inhibitor (0.05 g/L) was diagnosed as HALE. And the onset frequency was significantly reduced during danazol treatment. Conclusions HALE with a familial hereditary tendency is a rare and life-threatening disease, which is easy to be misdiagnosed. Clinicians should enhance awareness of it to avoid serious complications.

    网友评论
    网友评论
    分享到微博
    发 布
    参考文献
    [1] Longhurst H, Cicardi M. Hereditary angio-oedema[J]. Lancet, 2012, 379(9814):474-481.
    [2] Zanichelli A, Azin GM, Wu MA, et al.Diagnosis, course, and management of angioedema in patients with acquired c1-inhibitor deficiency[J]. J Allergy Clin Immunol Pract, 2017, 5(5):1307-1313.
    [3] 中华医学会变态反应学分会, 中国医师协会变态反应医师分会.遗传性血管性水肿的诊断和治疗专家共识[J].中华临床免疫和变态反应杂志, 2019, 13(1):1-4.
    [4] Xu YY, Jiang Y, Zhi YX, et al. Clinical features of hereditary angioedema in Chinese patients:new findings and differences from other populations[J].Eur J Dermatol, 2013, 23(4):500-504.
    [5] 吴振恭, 熊俊, 陈金, 等.家族性遗传性血管神经性水肿多次急性发作1例[J].中国眼耳鼻喉科杂志, 2015, 15(3):211-212.
    [6] 姚小坚, 秦昆, 张堂德.遗传性血管性水肿防治的研究进展[J].皮肤性病诊疗学杂志, 2018, 25(1):53-56.
    [7] 李景丽, 胡蓉, 何时知.遗传性血管性水肿并发喉梗阻二例[J].中华耳鼻咽喉头颈外科杂志, 2019, 54(12):937-939.
    [8] Longhurst H, Cicardi M, Craig T, et al. Prevention of hereditary angioedema attacks with a subcutaneous C1 inhibitor[J]. N Engl J Med, 2017, 376(12):1131-1140.
    [9] Gupta R, Balduzzi J, Davis-Lorton M. C1-esterase inhibitor (cinryze®) use in the treatment of pediatric hereditary angioedema[J]. Immunotherapy, 2018, 10(8):635-642.
    [10] Longhurst H, Zinser E.Prophylactic therapy for hereditary angioedema[J].Immunol Allergy Clin Noah Am, 2017, 37(3):557-570.
    引证文献
引用本文

李燕萍,胡瑞利.遗传性血管神经性喉水肿1例[J].中国耳鼻咽喉颅底外科杂志,2021,27(5):540-542

复制
分享
文章指标
  • 点击次数:66
  • 下载次数: 320
历史
  • 收稿日期:2020-09-21
  • 在线发布日期: 2021-10-29
温馨提示

本刊唯一投稿网址:www.xyosbs.com
唯一办公邮箱:xyent@126.com
编辑部联系电话:0731-84327210,84327469
本刊从未委托任何单位、个人及其他网站代理征稿及办理其他业务联系,谨防上当受骗!

关闭